CDK2 and acute lymphoblastic leukemia: Inhibition of Notch1 activity using Notch1-targeted siRNA reversed hypoxia-induced changes in expression of cell cycle regulatory proteins (CDK2, CyclinD1 and p21), thus repressed the hypoxia-induced proliferation of T-ALL cells.